reference/28273074

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28273074

Outgoing Links

Predicate	Object
contentType	Letter\|Comment
endingPage	5
issn	1473-4877
issueIdentifier	7
pageRange	1164; author reply 1164-5
publicationName	Current medical research and opinion
startingPage	1164; author reply 1164
bibliographicCitation	Wu E, Chen L. Re: Ulcickas Yood M, Oliveria SA, Cziraky M, et al. Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. Curr Med Res Opin 2012, 28(2): 213-19. Curr Med Res Opin. 2012 Jul;28(7):1164; author reply 1164–5. doi: 10.1185/03007995.2012.703135. PMID: 22697275.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15552c9620a437059ac5c8cce700ed36 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_821ac76078b4af1213c3275bab0dce68
date	201207
identifier	https://pubmed.ncbi.nlm.nih.gov/22697275 https://doi.org/10.1185/03007995.2012.703135
isPartOf	https://portal.issn.org/resource/ISSN/1473-4877 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3218
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	Re: Ulcickas Yood M, Oliveria SA, Cziraky M, et al. Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. Curr Med Res Opin 2012, 28(2): 213-19
discusses	http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0021333
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D055118 http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D013844Q000627 http://id.nlm.nih.gov/mesh/D015464Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644241

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247851103

Total number of triples: 32.